Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review

April 2021 | 59 pages | ID: S14F7D94B13EN
GlobalData

Abstracts

Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to the biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentors, moisture analyzers, filters, bioreactors, shakers, virus purification kits and centrifuges, among others. SSB services include bioprocess development and engineering, protein expression systems, media and process; instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa and Asia-Pacific. SSB is headquartered in Aubagne, Provence-Alpes-Cote d'Azur, France.

Sartorius Stedim Biotech SA Key Recent Developments

Mar 18,2021: Sartorius Stedim Biotech increases its full-year 2021 guidance
Feb 18,2021: Sartorius Stedim Biotech looks back on a very successful 2020 and expects further strong growth
Jan 27,2021: Sartorius closes 2020 with strong growth to well over 2 billion euros and a further increase in profitability
Jan 21,2021: Sartorius Stedim Biotech's $1.5 million donation creates cell culture facility at Penn State University
Jan 15,2021: Sartorius partners with RoosterBio to advance cell and gene therapy manufacturing

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Sartorius Stedim Biotech SA - Key Facts
Sartorius Stedim Biotech SA - Key Employees
Sartorius Stedim Biotech SA - Key Employee Biographies
Sartorius Stedim Biotech SA - Major Products and Services
Sartorius Stedim Biotech SA - History
Sartorius Stedim Biotech SA - Company Statement
Sartorius Stedim Biotech SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sartorius Stedim Biotech SA - Business Description
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: EMEA
Performance
Sartorius Stedim Biotech SA - Corporate Strategy
Sartorius Stedim Biotech SA - SWOT Analysis
SWOT Analysis - Overview
Sartorius Stedim Biotech SA - Strengths
Sartorius Stedim Biotech SA - Weaknesses
Sartorius Stedim Biotech SA - Opportunities
Sartorius Stedim Biotech SA - Threats
Sartorius Stedim Biotech SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
Sartorius Stedim Biotech SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 18, 2021: Sartorius Stedim Biotech increases its full-year 2021 guidance
Feb 18, 2021: Sartorius Stedim Biotech looks back on a very successful 2020 and expects further strong growth
Jan 27, 2021: Sartorius closes 2020 with strong growth to well over 2 billion euros and a further increase in profitability
Jan 21, 2021: Sartorius Stedim Biotech's $1.5 million donation creates cell culture facility at Penn State University
Jan 15, 2021: Sartorius partners with RoosterBio to advance cell and gene therapy manufacturing
Oct 20, 2020: Strong profitable growth at Sartorius Stedim Biotech
Jul 21, 2020: Sartorius Stedim Biotech with dynamic growth in the first half; 2020 revenue and earnings forecast raised
Jul 15, 2020: Sartorius Stedim Biotech increases its full-year 2020 guidance
Apr 21, 2020: Sartorius Stedim Biotech with a strong start in 2020
Mar 17, 2020: Sartorius Stedim Biotech postpones Annual Shareholders' Meeting

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sartorius Stedim Biotech SA, Key Facts
Sartorius Stedim Biotech SA, Key Employees
Sartorius Stedim Biotech SA, Key Employee Biographies
Sartorius Stedim Biotech SA, Major Products and Services
Sartorius Stedim Biotech SA, History
Sartorius Stedim Biotech SA, Subsidiaries
Sartorius Stedim Biotech SA, Key Competitors
Sartorius Stedim Biotech SA, Ratios based on current share price
Sartorius Stedim Biotech SA, Annual Ratios
Sartorius Stedim Biotech SA, Annual Ratios (Cont...1)
Sartorius Stedim Biotech SA, Annual Ratios (Cont...2)
Sartorius Stedim Biotech SA, Interim Ratios
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Type, 2015 to YTD 2021
Sartorius Stedim Biotech SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Sartorius Stedim Biotech SA, Performance Chart (2016 - 2020)
Sartorius Stedim Biotech SA, Ratio Charts
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2015 to YTD 2021
Sartorius Stedim Biotech SA, Medical Equipment, Deals by Type, 2015 to YTD 2021